International Journal of Bipolar Disorders has been accepted for indexing in the Science Citation Index Expanded (SCIE) by Clarivate Analytics and is expected to receive its first Impact Factor in the summer of 2019.
IJBD is also indexed by PubMed Central and the Directory of Open Access Journals (DOAJ). All articles will be indexed in both services shortly after publication. Submit your article now!
Thematic Series: Controversies in Bipolar Disorders
While pharmacotherapy and other biological treatment options form the foundation for successful treatment of bipolar disorder for more than seven decades, several therapeutic interventions are still controversial and sometimes its applications may differ across continents, countries or clinical settings quite significantly. This collection of articles aims to present four areas of controversy and uncertainty in bipolar disorder seeking to identify reasons for some of the dilemmas and future solutions to it. Read the series here.
Aims and scope
International Journal of Bipolar Disorders is affiliated with IGSLI (International Group for The Study of Lithium Treated Patients)
Annual Journal Metrics
45 days to first decision for reviewed manuscripts only
44 days to first decision for all manuscripts
80 days from submission to acceptance
52 days from acceptance to publication
185 Altmetric Mentions
- ISSN: 2194-7511 (electronic)